+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Gastric Space-Occupying Device Market - Global Forecast 2026-2032

  • Report

  • 185 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6120615
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Gastric Space-Occupying Device Market is projected to reach USD 363.11 Million in 2026. It is expected to continue growing at a CAGR of 13.90%, reaching USD 810.45 Million by 2032.

Gastric Space-Occupying Devices: Executive Overview

Gastric space-occupying devices are minimally invasive weight-management interventions designed to occupy volume in the stomach and promote earlier satiety. The category includes swallowable, endoscopically placed, and fluid- or gas-filled devices. Adoption is shaped by obesity prevalence, demand for non-surgical treatment options, clinical evidence, device durability, procedural capacity, reimbursement, and post-procedure monitoring requirements.

How Clinical Practice and Regulation Are Changing

The landscape is shifting toward less invasive interventions, stronger patient-selection protocols, and closer integration with nutrition and behavioral support. Regulators and healthcare providers increasingly emphasize evidence on safety, tolerability, durability of weight reduction, explantation or retrieval requirements, and outcomes beyond short-term weight loss. Market access also depends on trained endoscopy teams, standardized follow-up, transparent informed consent, and clear management of adverse events such as nausea, vomiting, dehydration, obstruction, or device-related complications.

Artificial Intelligence Strengthens Selection, Monitoring, and Evidence Generation

Artificial intelligence can support gastric space-occupying device care by helping clinicians stratify candidates using demographic, clinical, laboratory, imaging, and behavioral data. Predictive tools may assist with identifying patients at higher risk of intolerance, non-response, or complications, while remote monitoring can flag symptom patterns that warrant clinical review. AI can also improve trial recruitment, real-world evidence analysis, procedure documentation, and post-market surveillance. Human oversight remains essential because training-data bias, limited external validation, privacy obligations, and the consequences of incorrect triage can affect patient safety.

Regional Insights: Access Depends on Obesity Burden, Endoscopy Capacity, and Reimbursement

North America combines substantial clinical awareness with established bariatric and endoscopic infrastructure, but coverage rules, out-of-pocket costs, and evidence requirements influence access. Latin America is shaped by uneven specialist availability, private-sector concentration, and differing regulatory pathways. Europe benefits from mature healthcare systems and active clinical evaluation, while national reimbursement and country-level guidance remain important. The Middle East is seeing greater attention to obesity management, with access varying according to public-sector capacity, private care, and medical-tourism activity. Africa faces constraints related to specialist workforce, diagnostic infrastructure, affordability, and follow-up continuity. Asia-Pacific presents diverse conditions: advanced endoscopy capabilities coexist with access gaps, and local prevalence patterns, cultural preferences, regulation, and healthcare financing strongly affect adoption.

Group Insights: Economic Blocs and Alliances Shape Implementation Conditions

ASEAN markets require adaptable approaches because regulatory systems, clinical capacity, and reimbursement differ substantially across member states. BRICS economies offer broad patient need and expanding healthcare capabilities, but procurement, affordability, and evidence requirements vary. The European Union benefits from shared regulatory principles alongside national differences in reimbursement and service delivery. G7 countries generally have strong specialist infrastructure and data capabilities, with scrutiny focused on clinical value, safety, and cost-effectiveness. GCC countries often combine advanced private healthcare capacity with strategic investment in obesity services, while workforce development and coordinated pathways remain important. NATO members represent diverse health systems, but many share priorities around resilient supply chains, evidence-based care, and specialist training.

Country Insights: National Pathways Determine Clinical Uptake

Australia has established endoscopic expertise, with access influenced by private care and public-system priorities. Brazil combines significant clinical need with regional variation in specialist and procedural access. Canada’s publicly oriented system makes provincial funding and wait times central considerations. China’s large healthcare system supports specialist growth, while regulatory review, hospital capability, and affordability shape use. France, Germany, Italy, and Spain operate within the European regulatory environment but differ in reimbursement, provider organization, and clinical adoption. India’s diverse public-private system creates both specialized centers and major access gaps. Japan emphasizes careful clinical evaluation, procedural quality, and an aging population’s healthcare needs. Mexico faces uneven distribution of specialist services and substantial private-sector influence. Russia’s access is affected by regulatory, economic, and healthcare-system conditions. South Korea has advanced digital and procedural capabilities, with adoption influenced by evidence and reimbursement. The United Kingdom’s use is shaped by national guidance, commissioning decisions, and capacity within specialist services. The United States has broad provider availability and high patient awareness, but payer coverage, clinical evidence, and follow-up costs remain decisive.

Priorities for Industry Leaders: Prove Value, Build Pathways, and Protect Patients

Industry leaders should prioritize robust evidence that evaluates clinically meaningful outcomes, durability, adverse events, quality of life, and the role of structured lifestyle support. They should develop clear patient-selection criteria, standardized training, retrieval and complication-management protocols, and transparent labeling. Partnerships with hospitals and clinicians can strengthen referral, follow-up, and data-collection pathways. Commercial strategies should distinguish regulatory approval from reimbursement and demonstrate value to payers through appropriate health-economic evidence. Digital monitoring and AI should be introduced with validation, cybersecurity, privacy safeguards, explainability, and clinician escalation processes. Supply continuity, post-market surveillance, and education for patients and providers should be treated as core operating requirements rather than secondary activities.

Research Methodology: Evidence-Led Assessment of the Device Landscape

This executive summary uses a structured qualitative assessment of gastric space-occupying devices, focusing on device formats, clinical use, safety considerations, regulatory and reimbursement conditions, healthcare infrastructure, and regional variation. Insights are organized across the specified regions, economic groups, and countries to identify common drivers and local implementation constraints. The assessment separates documented structural conditions from forward-looking interpretation and avoids unsupported estimates, market sizing, market shares, and forecasts. Country and regional observations should be validated against current regulatory decisions, clinical guidelines, peer-reviewed studies, reimbursement policies, and provider-level evidence before investment or clinical decisions are made.

Conclusion: Sustainable Adoption Requires Evidence and Integrated Care

Gastric space-occupying devices occupy a distinct position between lifestyle management, pharmacological treatment, and bariatric surgery. Their long-term role will depend less on procedural novelty than on reproducible patient outcomes, safe delivery, appropriate follow-up, and integration with multidisciplinary obesity care. Regional and national differences in regulation, financing, specialist capacity, and patient preference will continue to shape adoption. Leaders that combine clinical rigor, responsible technology use, transparent value demonstration, and durable care pathways will be best positioned to support safe and meaningful patient access.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Gastric Space-Occupying Device Market, by Product Type
7.1. Introduction
7.2. Adjustable
7.3. Dual Fluid-Gas
7.4. Single Fluid-Filled
7.5. Single Gas-Filled
8. Gastric Space-Occupying Device Market, by Route Of Administration
8.1. Introduction
8.2. Endoscopic
8.3. Swallowable
9. Gastric Space-Occupying Device Market, by Duration Of Placement
9.1. Introduction
9.2. Long-Term
9.3. Short-Term
10. Gastric Space-Occupying Device Market, by End User
10.1. Introduction
10.2. Ambulatory Surgical Centers
10.3. Bariatric Clinics
10.4. Hospitals
11. Gastric Space-Occupying Device Market, by Distribution Channel
11.1. Introduction
11.2. Direct Sales
11.3. Distributors
12. Gastric Space-Occupying Device Market, by Region
12.1. Introduction
12.2. Asia-Pacific
12.3. North America
12.4. Latin America
12.5. Europe
12.6. Middle East
12.7. Africa
13. Gastric Space-Occupying Device Market, by Group
13.1. Introduction
13.2. ASEAN
13.3. GCC
13.4. European Union
13.5. BRICS
13.6. G7
13.7. NATO
14. Gastric Space-Occupying Device Market, by Country
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. United Kingdom
14.7. Germany
14.8. France
14.9. Russia
14.10. Italy
14.11. Spain
14.12. China
14.13. India
14.14. Japan
14.15. Australia
14.16. South Korea
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. Market Concentration Analysis, 2025
15.2.1. Concentration Ratio (CR)
15.2.2. Herfindahl Hirschman Index (HHI)
15.3. Recent Developments & Impact Analysis, 2025
15.4. Product Portfolio Analysis, 2025
15.5. Benchmarking Analysis, 2025
16. Company Profiles
16.1. Allurion Technologies, Inc.
16.2. Apollo Endosurgery, Inc.
16.3. BaroNova Therapeutics
16.4. Districlass Medical
16.5. Endalis
16.6. Endogastric Solutions
16.7. Fengh Medical
16.8. G-Surgery
16.9. Helioscopie Medical Implants
16.10. Lexel Medical
16.11. Life Partners Europe
16.12. Medicone
16.13. Medsil
16.14. Obalon Therapeutics, Inc.
16.15. Phagia Technologies
16.16. ReShape Lifesciences Inc.
16.17. Silimed
16.18. Silimed Ltda
16.19. Spatz Medical Ltd.
16.20. Tulip Medical
17. Key Experts
LIST OF FIGURES
FIGURE 1. Global Gastric Space-Occupying Device Market, Years Considered for the Study
FIGURE 2. Global Gastric Space-Occupying Device Market, Research Design
FIGURE 3. Global Gastric Space-Occupying Device Market, Research Framework
FIGURE 4. Global Gastric Space-Occupying Device Market, Data Triangulation
FIGURE 5. Global Gastric Space-Occupying Device Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Gastric Space-Occupying Device Market Size, by Product Type, 2025 vs 2032 (%)
FIGURE 7. Global Gastric Space-Occupying Device Market Size, by Product Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Gastric Space-Occupying Device Market Size, by Route Of Administration, 2025 vs 2032 (%)
FIGURE 9. Global Gastric Space-Occupying Device Market Size, by Route Of Administration, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Gastric Space-Occupying Device Market Size, by Duration Of Placement, 2025 vs 2032 (%)
FIGURE 11. Global Gastric Space-Occupying Device Market Size, by Duration Of Placement, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Gastric Space-Occupying Device Market Size, by End User, 2025 vs 2032 (%)
FIGURE 13. Global Gastric Space-Occupying Device Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Gastric Space-Occupying Device Market Size, by Distribution Channel, 2025 vs 2032 (%)
FIGURE 15. Global Gastric Space-Occupying Device Market Size, by Distribution Channel, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Gastric Space-Occupying Device Market Size, by Region, 2025 vs 2032 (%)
FIGURE 17. Global Gastric Space-Occupying Device Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Gastric Space-Occupying Device Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Gastric Space-Occupying Device Market Size, by Country, 2025 vs 2032 (%)
FIGURE 20. Global Gastric Space-Occupying Device Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global Gastric Space-Occupying Device Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Gastric Space-Occupying Device Market Segmentation & Coverage
TABLE 2. Global Gastric Space-Occupying Device Market Size, 2017-2032 (USD Million)
TABLE 3. Global Gastric Space-Occupying Device Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 4. Global Adjustable Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Adjustable Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Adjustable Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Dual Fluid-Gas Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Dual Fluid-Gas Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Dual Fluid-Gas Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Single Fluid-Filled Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Single Fluid-Filled Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Single Fluid-Filled Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Single Gas-Filled Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Single Gas-Filled Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Single Gas-Filled Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Gastric Space-Occupying Device Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 17. Global Endoscopic Market Size, by Region, 2017-2032 (USD Million)
TABLE 18. Global Endoscopic Market Size, by Group, 2017-2032 (USD Million)
TABLE 19. Global Endoscopic Market Size, by Country, 2017-2032 (USD Million)
TABLE 20. Global Swallowable Market Size, by Region, 2017-2032 (USD Million)
TABLE 21. Global Swallowable Market Size, by Group, 2017-2032 (USD Million)
TABLE 22. Global Swallowable Market Size, by Country, 2017-2032 (USD Million)
TABLE 23. Global Gastric Space-Occupying Device Market Size, by Duration Of Placement, 2017-2032 (USD Million)
TABLE 24. Global Long-Term Market Size, by Region, 2017-2032 (USD Million)
TABLE 25. Global Long-Term Market Size, by Group, 2017-2032 (USD Million)
TABLE 26. Global Long-Term Market Size, by Country, 2017-2032 (USD Million)
TABLE 27. Global Short-Term Market Size, by Region, 2017-2032 (USD Million)
TABLE 28. Global Short-Term Market Size, by Group, 2017-2032 (USD Million)
TABLE 29. Global Short-Term Market Size, by Country, 2017-2032 (USD Million)
TABLE 30. Global Gastric Space-Occupying Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 31. Global Ambulatory Surgical Centers Market Size, by Region, 2017-2032 (USD Million)
TABLE 32. Global Ambulatory Surgical Centers Market Size, by Group, 2017-2032 (USD Million)
TABLE 33. Global Ambulatory Surgical Centers Market Size, by Country, 2017-2032 (USD Million)
TABLE 34. Global Bariatric Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 35. Global Bariatric Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 36. Global Bariatric Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 37. Global Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 38. Global Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 39. Global Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 40. Global Gastric Space-Occupying Device Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 41. Global Direct Sales Market Size, by Region, 2017-2032 (USD Million)
TABLE 42. Global Direct Sales Market Size, by Group, 2017-2032 (USD Million)
TABLE 43. Global Direct Sales Market Size, by Country, 2017-2032 (USD Million)
TABLE 44. Global Distributors Market Size, by Region, 2017-2032 (USD Million)
TABLE 45. Global Distributors Market Size, by Group, 2017-2032 (USD Million)
TABLE 46. Global Distributors Market Size, by Country, 2017-2032 (USD Million)
TABLE 47. Global Gastric Space-Occupying Device Market Size, by Region, 2017-2032 (USD Million)
TABLE 48. Asia-Pacific Gastric Space-Occupying Device Market Size, by Region, 2017-2032 (USD Million)
TABLE 49. Asia-Pacific Gastric Space-Occupying Device Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 50. Asia-Pacific Gastric Space-Occupying Device Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 51. Asia-Pacific Gastric Space-Occupying Device Market Size, by Duration Of Placement, 2017-2032 (USD Million)
TABLE 52. Asia-Pacific Gastric Space-Occupying Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 53. Asia-Pacific Gastric Space-Occupying Device Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 54. North America Gastric Space-Occupying Device Market Size, by Region, 2017-2032 (USD Million)
TABLE 55. North America Gastric Space-Occupying Device Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 56. North America Gastric Space-Occupying Device Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 57. North America Gastric Space-Occupying Device Market Size, by Duration Of Placement, 2017-2032 (USD Million)
TABLE 58. North America Gastric Space-Occupying Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 59. North America Gastric Space-Occupying Device Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 60. Latin America Gastric Space-Occupying Device Market Size, by Region, 2017-2032 (USD Million)
TABLE 61. Latin America Gastric Space-Occupying Device Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 62. Latin America Gastric Space-Occupying Device Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 63. Latin America Gastric Space-Occupying Device Market Size, by Duration Of Placement, 2017-2032 (USD Million)
TABLE 64. Latin America Gastric Space-Occupying Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 65. Latin America Gastric Space-Occupying Device Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 66. Europe Gastric Space-Occupying Device Market Size, by Region, 2017-2032 (USD Million)
TABLE 67. Europe Gastric Space-Occupying Device Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 68. Europe Gastric Space-Occupying Device Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 69. Europe Gastric Space-Occupying Device Market Size, by Duration Of Placement, 2017-2032 (USD Million)
TABLE 70. Europe Gastric Space-Occupying Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 71. Europe Gastric Space-Occupying Device Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 72. Middle East Gastric Space-Occupying Device Market Size, by Region, 2017-2032 (USD Million)
TABLE 73. Middle East Gastric Space-Occupying Device Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 74. Middle East Gastric Space-Occupying Device Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 75. Middle East Gastric Space-Occupying Device Market Size, by Duration Of Placement, 2017-2032 (USD Million)
TABLE 76. Middle East Gastric Space-Occupying Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 77. Middle East Gastric Space-Occupying Device Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 78. Africa Gastric Space-Occupying Device Market Size, by Region, 2017-2032 (USD Million)
TABLE 79. Africa Gastric Space-Occupying Device Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 80. Africa Gastric Space-Occupying Device Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 81. Africa Gastric Space-Occupying Device Market Size, by Duration Of Placement, 2017-2032 (USD Million)
TABLE 82. Africa Gastric Space-Occupying Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 83. Africa Gastric Space-Occupying Device Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 84. Global Gastric Space-Occupying Device Market Size, by Group, 2017-2032 (USD Million)
TABLE 85. ASEAN Gastric Space-Occupying Device Market Size, by Group, 2017-2032 (USD Million)
TABLE 86. ASEAN Gastric Space-Occupying Device Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 87. ASEAN Gastric Space-Occupying Device Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 88. ASEAN Gastric Space-Occupying Device Market Size, by Duration Of Placement, 2017-2032 (USD Million)
TABLE 89. ASEAN Gastric Space-Occupying Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 90. ASEAN Gastric Space-Occupying Device Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 91. GCC Gastric Space-Occupying Device Market Size, by Group, 2017-2032 (USD Million)
TABLE 92. GCC Gastric Space-Occupying Device Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 93. GCC Gastric Space-Occupying Device Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 94. GCC Gastric Space-Occupying Device Market Size, by Duration Of Placement, 2017-2032 (USD Million)
TABLE 95. GCC Gastric Space-Occupying Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 96. GCC Gastric Space-Occupying Device Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 97. European Union Gastric Space-Occupying Device Market Size, by Group, 2017-2032 (USD Million)
TABLE 98. European Union Gastric Space-Occupying Device Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 99. European Union Gastric Space-Occupying Device Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 100. European Union Gastric Space-Occupying Device Market Size, by Duration Of Placement, 2017-2032 (USD Million)
TABLE 101. European Union Gastric Space-Occupying Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 102. European Union Gastric Space-Occupying Device Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 103. BRICS Gastric Space-Occupying Device Market Size, by Group, 2017-2032 (USD Million)
TABLE 104. BRICS Gastric Space-Occupying Device Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 105. BRICS Gastric Space-Occupying Device Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 106. BRICS Gastric Space-Occupying Device Market Size, by Duration Of Placement, 2017-2032 (USD Million)
TABLE 107. BRICS Gastric Space-Occupying Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 108. BRICS Gastric Space-Occupying Device Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 109. G7 Gastric Space-Occupying Device Market Size, by Group, 2017-2032 (USD Million)
TABLE 110. G7 Gastric Space-Occupying Device Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 111. G7 Gastric Space-Occupying Device Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 112. G7 Gastric Space-Occupying Device Market Size, by Duration Of Placement, 2017-2032 (USD Million)
TABLE 113. G7 Gastric Space-Occupying Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 114. G7 Gastric Space-Occupying Device Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 115. NATO Gastric Space-Occupying Device Market Size, by Group, 2017-2032 (USD Million)
TABLE 116. NATO Gastric Space-Occupying Device Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 117. NATO Gastric Space-Occupying Device Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 118. NATO Gastric Space-Occupying Device Market Size, by Duration Of Placement, 2017-2032 (USD Million)
TABLE 119. NATO Gastric Space-Occupying Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 120. NATO Gastric Space-Occupying Device Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 121. Global Gastric Space-Occupying Device Market Size, by Country, 2017-2032 (USD Million)
TABLE 122. United States Gastric Space-Occupying Device Market Size, 2017-2032 (USD Million)
TABLE 123. United States Gastric Space-Occupying Device Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 124. United States Gastric Space-Occupying Device Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 125. United States Gastric Space-Occupying Device Market Size, by Duration Of Placement, 2017-2032 (USD Million)
TABLE 126. United States Gastric Space-Occupying Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 127. United States Gastric Space-Occupying Device Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 128. Canada Gastric Space-Occupying Device Market Size, 2017-2032 (USD Million)
TABLE 129. Canada Gastric Space-Occupying Device Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 130. Canada Gastric Space-Occupying Device Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 131. Canada Gastric Space-Occupying Device Market Size, by Duration Of Placement, 2017-2032 (USD Million)
TABLE 132. Canada Gastric Space-Occupying Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 133. Canada Gastric Space-Occupying Device Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 134. Mexico Gastric Space-Occupying Device Market Size, 2017-2032 (USD Million)
TABLE 135. Mexico Gastric Space-Occupying Device Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 136. Mexico Gastric Space-Occupying Device Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 137. Mexico Gastric Space-Occupying Device Market Size, by Duration Of Placement, 2017-2032 (USD Million)
TABLE 138. Mexico Gastric Space-Occupying Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 139. Mexico Gastric Space-Occupying Device Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 140. Brazil Gastric Space-Occupying Device Market Size, 2017-2032 (USD Million)
TABLE 141. Brazil Gastric Space-Occupying Device Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 142. Brazil Gastric Space-Occupying Device Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 143. Brazil Gastric Space-Occupying Device Market Size, by Duration Of Placement, 2017-2032 (USD Million)
TABLE 144. Brazil Gastric Space-Occupying Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 145. Brazil Gastric Space-Occupying Device Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 146. United Kingdom Gastric Space-Occupying Device Market Size, 2017-2032 (USD Million)
TABLE 147. United Kingdom Gastric Space-Occupying Device Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 148. United Kingdom Gastric Space-Occupying Device Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 149. United Kingdom Gastric Space-Occupying Device Market Size, by Duration Of Placement, 2017-2032 (USD Million)
TABLE 150. United Kingdom Gastric Space-Occupying Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 151. United Kingdom Gastric Space-Occupying Device Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 152. Germany Gastric Space-Occupying Device Market Size, 2017-2032 (USD Million)
TABLE 153. Germany Gastric Space-Occupying Device Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 154. Germany Gastric Space-Occupying Device Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 155. Germany Gastric Space-Occupying Device Market Size, by Duration Of Placement, 2017-2032 (USD Million)
TABLE 156. Germany Gastric Space-Occupying Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 157. Germany Gastric Space-Occupying Device Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 158. France Gastric Space-Occupying Device Market Size, 2017-2032 (USD Million)
TABLE 159. France Gastric Space-Occupying Device Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 160. France Gastric Space-Occupying Device Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 161. France Gastric Space-Occupying Device Market Size, by Duration Of Placement, 2017-2032 (USD Million)
TABLE 162. France Gastric Space-Occupying Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 163. France Gastric Space-Occupying Device Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 164. Russia Gastric Space-Occupying Device Market Size, 2017-2032 (USD Million)
TABLE 165. Russia Gastric Space-Occupying Device Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 166. Russia Gastric Space-Occupying Device Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 167. Russia Gastric Space-Occupying Device Market Size, by Duration Of Placement, 2017-2032 (USD Million)
TABLE 168. Russia Gastric Space-Occupying Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 169. Russia Gastric Space-Occupying Device Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 170. Italy Gastric Space-Occupying Device Market Size, 2017-2032 (USD Million)
TABLE 171. Italy Gastric Space-Occupying Device Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 172. Italy Gastric Space-Occupying Device Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 173. Italy Gastric Space-Occupying Device Market Size, by Duration Of Placement, 2017-2032 (USD Million)
TABLE 174. Italy Gastric Space-Occupying Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 175. Italy Gastric Space-Occupying Device Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 176. Spain Gastric Space-Occupying Device Market Size, 2017-2032 (USD Million)
TABLE 177. Spain Gastric Space-Occupying Device Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 178. Spain Gastric Space-Occupying Device Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 179. Spain Gastric Space-Occupying Device Market Size, by Duration Of Placement, 2017-2032 (USD Million)
TABLE 180. Spain Gastric Space-Occupying Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 181. Spain Gastric Space-Occupying Device Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 182. China Gastric Space-Occupying Device Market Size, 2017-2032 (USD Million)
TABLE 183. China Gastric Space-Occupying Device Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 184. China Gastric Space-Occupying Device Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 185. China Gastric Space-Occupying Device Market Size, by Duration Of Placement, 2017-2032 (USD Million)
TABLE 186. China Gastric Space-Occupying Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 187. China Gastric Space-Occupying Device Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 188. India Gastric Space-Occupying Device Market Size, 2017-2032 (USD Million)
TABLE 189. India Gastric Space-Occupying Device Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 190. India Gastric Space-Occupying Device Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 191. India Gastric Space-Occupying Device Market Size, by Duration Of Placement, 2017-2032 (USD Million)
TABLE 192. India Gastric Space-Occupying Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 193. India Gastric Space-Occupying Device Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 194. Japan Gastric Space-Occupying Device Market Size, 2017-2032 (USD Million)
TABLE 195. Japan Gastric Space-Occupying Device Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 196. Japan Gastric Space-Occupying Device Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 197. Japan Gastric Space-Occupying Device Market Size, by Duration Of Placement, 2017-2032 (USD Million)
TABLE 198. Japan Gastric Space-Occupying Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 199. Japan Gastric Space-Occupying Device Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 200. Australia Gastric Space-Occupying Device Market Size, 2017-2032 (USD Million)
TABLE 201. Australia Gastric Space-Occupying Device Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 202. Australia Gastric Space-Occupying Device Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 203. Australia Gastric Space-Occupying Device Market Size, by Duration Of Placement, 2017-2032 (USD Million)
TABLE 204. Australia Gastric Space-Occupying Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 205. Australia Gastric Space-Occupying Device Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 206. South Korea Gastric Space-Occupying Device Market Size, 2017-2032 (USD Million)
TABLE 207. South Korea Gastric Space-Occupying Device Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 208. South Korea Gastric Space-Occupying Device Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 209. South Korea Gastric Space-Occupying Device Market Size, by Duration Of Placement, 2017-2032 (USD Million)
TABLE 210. South Korea Gastric Space-Occupying Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 211. South Korea Gastric Space-Occupying Device Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 212. Global Gastric Space-Occupying Device Market Share, by Key Player, 2025
TABLE 213. Global Gastric Space-Occupying Device Market, Key Experts

Companies Mentioned

  • Allurion Technologies, Inc.
  • Apollo Endosurgery, Inc.
  • BaroNova Therapeutics
  • Districlass Medical
  • Endalis
  • Endogastric Solutions
  • Fengh Medical
  • G‑Surgery
  • Helioscopie Medical Implants
  • Lexel Medical
  • Life Partners Europe
  • Medicone
  • Medsil
  • Obalon Therapeutics, Inc.
  • Phagia Technologies
  • ReShape Lifesciences Inc.
  • Silimed
  • Silimed Ltda
  • Spatz Medical Ltd.
  • Tulip Medical